Adial Pharmaceuticals, Inc

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2025 Q2	9	166 k	$50.1 k	$0
2025 Q1	13	235 k	$149 k	$0
2024 Q4	14	290 k	$292 k	$0
2024 Q3	12	194 k	$194 k	$0
2024 Q2	17	284 k	$326 k	$0
2024 Q1	18	176 k	$233 k	$0
2023 Q4	19	267 k	$496 k	$0
2023 Q3	11	57.0 k	$158 k	$0